fluorescein-5-isothiocyanate has been researched along with Endomyocardial Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierhuizen, MF; de Bakker, JM; de Jong, S; Hermans, RH; Losen, M; Prinzen, FW; van Middendorp, LB; van Rijen, HV; van Zandvoort, MA; Vos, MA | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Ex vivo and in vivo administration of fluorescent CNA35 specifically marks cardiac fibrosis.
Topics: Animals; Biomarkers; Cell Adhesion Molecules; Dogs; Endomyocardial Fibrosis; Fluorescein-5-isothiocyanate; Mice; Myocytes, Cardiac; Rats | 2014 |